Rangering i aksjer
#33058
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Handel Arctic Bioscience AS (ABS)
Pris ABS pris med markedsverdi på B
Markedsverdi av Arctic Bioscience AS(ABS)
Markedsverdi: $8.48M
Per August 2026 har Arctic Bioscience AS en markedsverdi på $8.48M. Dette gjør Arctic Bioscience AS til det 33058th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Arctic Bioscience AS fra 2021 til 2026
ABS sammenlignet med topp 5 mest populære stocks
| Pris på ABS |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.470T
|
+64,527,931.12%
|
|
|
|
|
$4.474T
|
+52,783,998.09%
|
|
|
|
|
$4.154T
|
+49,004,273.27%
|
|
|
|
|
$3.601T
|
+42,480,697.83%
|
|
|
|
|
$2.829T
|
+33,373,986.80%
|
